Pharmaceutical Industries Ltd.
Your browser does not support iframes.
See Teva's sites around the world
Japan & S. Korea
Bosnia & Herzegovina
Want to find out more about Teva's locations and phone numbers?
Visit Teva Worldwide
Board of Directors
2016 Annual Report on Form 20-F
Notice of Annual Meeting of Shareholders 2015 – Proxy Statement
Over the Counter (OTC)
Central Nervous System (CNS)
Teva at IATI BIOMED 2015
Leading the Fight for Cures
National Network of Excellence
Global Patient Advocacy Engagement
2014 Full Report
Previous CSR Reports
Teva Fact Sheet
PLIVA Awarded Two Golden Keys
Webcasts and Presentations
Grow with the Best
Our Guiding Values
Grow with the Best
Go to Parent
Global Leadership in Active Pharmaceutical Ingredients
Delivering the broadest global portfolio in the active pharmaceutical ingredients (API) industry, and an 80 year track record of excellence, tapi is your ideal API partner.
Share on Facebook
Share on LinkedIn
A standalone business unit of Teva Pharmaceutical Industries, tapi supplies high quality APIs to nearly 1,000 customers in over 100 countries. Teva tapi is a leading global manufacturer of APIs, providing more than 300 quality APIs manufactured at 19 state-of-the-art production facilities. Employing over 5,000 highly-trained professionals, tapi is wholly committed to environmental, health and safety (EHS) matters in all aspects of our business to ensure sustainable supplies.
At tapi, we take our partnerships with our clients very seriously, and we view our partners’ success as our own. Our many years of accrued expertise and knowledge provides significant added value to our partners. We work tirelessly to help them deliver high-quality generic and innovative products to market quickly and effectively. Continuously nurturing these fruitful partnerships through close cooperation, tapi offers superior product quality and end-to-end support. We do this by assigning designated personnel to each customer. This includes highly-responsive customer service representatives, account managers and scientific and logistical support, as well as R&D, QA, RA, IP and marketing personnel.
Our large-scale ongoing investment in R&D enables timely introduction of new products to market, generating a steady flow of APIs – on average 15 new products annually. Located in 7 research and development centers, our expert teams comprise over 700 world-class R&D scientists and research associates, specializing in such fields as chemical synthesis, fermentation, high potency APIs, natural products and plant extraction, peptides, vitamin D derivatives, prostaglandins, and analytical and solid-state R&D.
In addition, our expert RA and QA teams maintain the highest global standards of quality and regulatory compliance, while our unparalleled IP personnel provides our customers with the freedom to operate, helping them to maintain a competitive edge in the market.
Moreover, tapi proactively initiates unannounced inspections and conducts product reviews. This ensures we are prepared for frequent FDA, MHRA/TGA and national MOH audits. In addition, we rigorously monitor of our API suppliers and management units, and continuously adjust to new FDA regulations regarding APIs. We also frequently publish updated guidelines to ensure continuous improvement.
Providing far more than APIs, tapi is committed to your success.
Contact us at
to find out how our global experience and expertise can work for you.
You May Also Like...
Prime Minister Stephen Harper Advances Canada - Israel Relations
Biologics at Teva
You are The Hero - Teva Hungary Launches New Resuscitation Program